Old Web
English
Sign In
Acemap
>
authorDetail
>
Michelle M. Cummins
Michelle M. Cummins
University of Sydney
Medicine
Chemotherapy
Bevacizumab
Capecitabine
Fluorouracil
2
Papers
325
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.
2021
Journal for ImmunoTherapy of Cancer
Yoland Antill
Peey-Sei Kok
Kristy P. Robledo
Sonia Yip
Michelle M. Cummins
Deborah Smith
Amanda B. Spurdle
Elizabeth H Barnes
Yeh Chen Lee
Michael Friedlander
Sally Baron-Hay
Catherine Shannon
Jermaine Coward
Philip Beale
Geraldine Goss
Tarek Meniawy
Janine M. Lombard
John Andrews
Martin R. Stockler
Linda Mileshkin
Show All
Source
Cite
Save
Citations (0)
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study
2010
Journal of Clinical Oncology
Niall C. Tebbutt
Kate Wilson
Val Gebski
Michelle M. Cummins
Diana Zannino
Guy van Hazel
Bridget A. Robinson
Adam Broad
Vinod Ganju
Stephen P. Ackland
Garry Forgeson
David Cunningham
Mark P Saunders
Martin R. Stockler
YuJo Chua
John R. Zalcberg
R. John Simes
Timothy J. Price
Show All
Source
Cite
Save
Citations (325)
1
map